Questioning the value of screening for gonorrhoea in symptomless heterosexual men

Pittrof R , Hitchings S , Fitzgerald M. Questioning the value of screening for gonorrhoea in symptomless heterosexual men. Int J STD AIDS 2009; 20: 741–4.

Lavelle SJ , Mallinson H , Henning SJ. Impact on gonorrhoea case reports through concomitant/dual testing in a chlamydia screening population in Liverpool. Sex Transm Infect 2007; 83: 593–4.

Lavelle SJ , Jones KE , Mallinson H , Webb A. Finding, confirming, and managing gonorrhoea in a population screened for Chlamydia using the Gen-Probe Aptima Combo2 assay. Sex Transm Infect 2006; 82: 221–4.

Mahto M , Zia S , Ritchie D , Mallinson H. Diagnosis, management and prevalence estimation of gonorrhoea: influences of Aptima Combo 2 assay with alternative target confirmation. Int J STD AIDS 2009; 20: 315–19.

Ryan C , Kudesia G , McIntyre S. BD ProbeTec ET assay for the diagnosis of gonorrhoea in a high-risk population: a protocol for replacing traditional microscopy and culture techniques. Sex Transm Infect 2007; 83: 175–80.

Health Protection Scotland, Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL). Guidance on the Introduction of Molecular Testing for Neisseria gonorrhoeae in Diagnostic Laboratories. 1 August 2007. See http://www.documents.hps.scot.nhs.uk/labs/sbstirl/naats-2007-08.pdf (last accessed 18 February 2010)